Merck insider trading
MRKfinancial statementsForm 4 filings on EDGAR129 transactions since Nov 1, 2024
From August 4, 2026 to November 1, 2026, 0 insiders at Merck bought $0 of stock in the open market, and 5 sold $30M. Officers and directors accounted for $0 of purchases and $30M of sales. The last reported transaction was an open-market sale by Guindo Chirfi on August 13, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through August 13, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $30MAug 4, 2026 – Nov 1, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
129 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Guindo Chirfi | EVP, Access, Policy & Comms | open-market sale | 10,000 | $135.00 | $1M | 36,613 | Aug 13, 2026 |
| Aug 12, 2026 | Zachary Jennifer | EVP, General Counsel | option exercise | 41,494 | $117.89 | $5M | 112,391 | Aug 13, 2026 |
| Aug 12, 2026 | Zachary Jennifer | EVP, General Counsel | option exercise | 13,433 | $84.71 | $1M | 125,824 | Aug 13, 2026 |
| Aug 12, 2026 | Zachary Jennifer | EVP, General Counsel | open-market sale | 80,315 | $133.46 | $11M | 45,509 | Aug 13, 2026 |
| Aug 12, 2026 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | open-market sale | 11,099 | $131.61 | $1M | 110,767 | Aug 12, 2026 |
| Aug 12, 2026 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | open-market sale | 600 | $132.04 | $79K | 110,167 | Aug 12, 2026 |
| Aug 11, 2026 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | open-market sale | 7,410 | $131.33 | $973K | 127,293 | Aug 12, 2026 |
| Aug 11, 2026 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | open-market sale | 5,427 | $132.35 | $718K | 121,866 | Aug 12, 2026 |
| Aug 10, 2026 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | open-market sale | 20,784 | $130.43 | $3M | 134,703 | Aug 12, 2026 |
| Aug 6, 2026 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | open-market sale | 805 | $131.02 | $105K | 160,732 | Aug 10, 2026 |
| Aug 6, 2026 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | open-market sale | 4,945 | $130.23 | $644K | 155,787 | Aug 10, 2026 |
| Aug 6, 2026 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | open-market sale | 300 | $131.02 | $39K | 155,487 | Aug 10, 2026 |
| Aug 6, 2026 | Guindo Chirfi | EVP, Access, Policy & Comms | open-market sale | 15,000 | $131.00 | $2M | 46,613 | Aug 7, 2026 |
| Aug 5, 2026 | Maraldo David R. | EVP & Pres. MMD | option exercise | 6,311 | $73.73 | $465K | 24,523 | Aug 7, 2026 |
| Aug 5, 2026 | Maraldo David R. | EVP & Pres. MMD | open-market sale | 6,311 | $128.72 | $812K | 18,212 | Aug 7, 2026 |
| Aug 5, 2026 | Maraldo David R. | EVP & Pres. MMD | option exercise | 9,709 | $87.10 | $846K | 27,921 | Aug 7, 2026 |
| Aug 5, 2026 | Maraldo David R. | EVP & Pres. MMD | open-market sale | 9,709 | $128.72 | $1M | 18,212 | Aug 7, 2026 |
| Aug 5, 2026 | Maraldo David R. | EVP & Pres. MMD | option exercise | 2,686 | $84.71 | $228K | 20,898 | Aug 7, 2026 |
| Aug 5, 2026 | Maraldo David R. | EVP & Pres. MMD | open-market sale | 2,686 | $128.72 | $346K | 18,212 | Aug 7, 2026 |
| Aug 5, 2026 | Williams David Michael | EVP,Chief Info&Digital Officer | option exercise | 4,600 | $77.62 | $357K | 36,316 | Aug 7, 2026 |
| Aug 5, 2026 | Williams David Michael | EVP,Chief Info&Digital Officer | open-market sale | 4,600 | $128.77 | $592K | 31,716 | Aug 7, 2026 |
| Aug 5, 2026 | Williams David Michael | EVP,Chief Info&Digital Officer | option exercise | 13,542 | $75.36 | $1M | 45,258 | Aug 7, 2026 |
| Aug 5, 2026 | Williams David Michael | EVP,Chief Info&Digital Officer | open-market sale | 13,542 | $128.77 | $2M | 31,716 | Aug 7, 2026 |
| Aug 5, 2026 | Williams David Michael | EVP,Chief Info&Digital Officer | option exercise | 34,705 | $73.73 | $3M | 66,421 | Aug 7, 2026 |
| Aug 5, 2026 | Williams David Michael | EVP,Chief Info&Digital Officer | open-market sale | 34,705 | $128.77 | $4M | 31,716 | Aug 7, 2026 |
| May 2, 2026 | Smart Dalton E. III | SVP Fin. - Global Controller | option exercise | 383 | $112.16 | $43K | 9,520 | May 5, 2026 |
| May 2, 2026 | Smart Dalton E. III | SVP Fin. - Global Controller | tax withholding | 132 | $112.16 | $15K | 9,388 | May 5, 2026 |
| May 2, 2026 | Maraldo David R. | EVP & Pres. MMD | option exercise | 552 | $112.16 | $62K | 18,371 | May 5, 2026 |
| May 2, 2026 | Maraldo David R. | EVP & Pres. MMD | tax withholding | 159 | $112.16 | $18K | 18,212 | May 5, 2026 |
| Apr 30, 2026 | Smart Dalton E. III | SVP Fin. - Global Controller | option exercise | 464 | $110.95 | $51K | 9,296 | May 1, 2026 |
| Apr 30, 2026 | Smart Dalton E. III | SVP Fin. - Global Controller | tax withholding | 159 | $110.95 | $18K | 9,137 | May 1, 2026 |
| Apr 30, 2026 | Larson Betty D | EVP, Chief HR Officer | option exercise | 11,350 | $110.95 | $1M | 18,917 | May 1, 2026 |
| Apr 30, 2026 | Larson Betty D | EVP, Chief HR Officer | tax withholding | 5,143 | $110.95 | $571K | 13,774 | May 1, 2026 |
| Apr 29, 2026 | Guindo Chirfi | EVP, Access, Policy & Comms | option exercise | 1,967 | $110.03 | $216K | 62,582 | May 1, 2026 |
| Apr 29, 2026 | Guindo Chirfi | EVP, Access, Policy & Comms | tax withholding | 969 | $110.03 | $107K | 61,613 | May 1, 2026 |
| Apr 29, 2026 | Chattopadhyay Sanat | Exe V-P & Pres. MMD | option exercise | 2,597 | $110.03 | $286K | 16,477 | May 1, 2026 |
| Apr 29, 2026 | Chattopadhyay Sanat | Exe V-P & Pres. MMD | tax withholding | 1,130 | $110.03 | $124K | 15,347 | May 1, 2026 |
| Apr 29, 2026 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | option exercise | 2,518 | $110.03 | $277K | 162,778 | May 1, 2026 |
| Apr 29, 2026 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | tax withholding | 1,241 | $110.03 | $137K | 161,537 | May 1, 2026 |
| Apr 29, 2026 | Williams David Michael | EVP,Chief Info&Digital Officer | option exercise | 1,377 | $110.03 | $152K | 32,395 | May 1, 2026 |
| Apr 29, 2026 | Williams David Michael | EVP,Chief Info&Digital Officer | tax withholding | 679 | $110.03 | $75K | 31,716 | May 1, 2026 |
| Apr 29, 2026 | Smart Dalton E. III | SVP Fin. - Global Controller | option exercise | 944 | $110.03 | $104K | 9,156 | May 1, 2026 |
| Apr 29, 2026 | Smart Dalton E. III | SVP Fin. - Global Controller | tax withholding | 324 | $110.03 | $36K | 8,832 | May 1, 2026 |
| Apr 29, 2026 | Li Dean Y | Executive VP & President, MRL | option exercise | 4,722 | $110.03 | $520K | 96,757 | May 1, 2026 |
| Apr 29, 2026 | Li Dean Y | Executive VP & President, MRL | tax withholding | 2,326 | $110.03 | $256K | 94,431 | May 1, 2026 |
| Apr 29, 2026 | Zachary Jennifer | EVP, General Counsel | option exercise | 2,951 | $110.03 | $325K | 72,351 | May 1, 2026 |
| Apr 29, 2026 | Zachary Jennifer | EVP, General Counsel | tax withholding | 1,454 | $110.03 | $160K | 70,897 | May 1, 2026 |
| Apr 29, 2026 | Larson Betty D | EVP, Chief HR Officer | option exercise | 2,085 | $110.03 | $229K | 8,282 | May 1, 2026 |
| Apr 29, 2026 | Larson Betty D | EVP, Chief HR Officer | tax withholding | 715 | $110.03 | $79K | 7,567 | May 1, 2026 |
| Apr 29, 2026 | Litchfield Caroline | EVP & CFO | option exercise | 3,935 | $110.03 | $433K | 94,239 | May 1, 2026 |
Who the insiders are
Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Zachary Jennifer | EVP, General Counsel | Aug 12, 2026 | option exercise | 112,391 | — | $25M (4) | 0 of 4 |
| DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | Aug 12, 2026 | open-market sale | 110,767 | — | $11M (9) | 0 of 9 |
| Guindo Chirfi | EVP, Access, Policy & Comms | Aug 13, 2026 | open-market sale | 36,613 | — | $8M (5) | 0 of 5 |
| Williams David Michael | EVP,Chief Info&Digital Officer | Aug 5, 2026 | option exercise | 36,316 | — | $8M (5) | 0 of 5 |
| Davis Robert M | Chairman, CEO & President, Director | Apr 29, 2026 | option exercise | 456,902 | — | $6M (2) | 0 of 2 |
| Litchfield Caroline | EVP & CFO | Apr 29, 2026 | option exercise | 94,239 | — | $5M (1) | 0 of 1 |
| Li Dean Y | Executive VP & President, MRL | Apr 29, 2026 | option exercise | 96,757 | — | $3M (2) | 0 of 2 |
| Maraldo David R. | EVP & Pres. MMD | Aug 5, 2026 | option exercise | 24,523 | — | $2M (3) | 0 of 3 |
| Oosthuizen Johannes Jacobus | EVP, Oncology & Int?l | Apr 29, 2026 | option exercise | 22,574 | — | $2M (1) | 0 of 1 |
| Smart Dalton E. III | SVP Fin. - Global Controller | May 2, 2026 | option exercise | 9,520 | — | $766K (2) | 0 of 2 |
| Downing Cristal N | Chief Comm. & Public Afrs Ofcr | Nov 10, 2025 | open-market sale | 0 | — | $616K (1) | 0 of 1 |
| Larson Betty D | EVP, Chief HR Officer | Apr 30, 2026 | option exercise | 18,917 | — | — | — |
| Romanelli Joseph | President, Human Health Int?l | Jan 26, 2026 | award | 28,739 | — | — | — |
| Chattopadhyay Sanat | Exe V-P & Pres. MMD | Apr 29, 2026 | option exercise | 16,477 | — | — | — |
| Thulin Inge G | Director | Feb 6, 2025 | open-market buy | 2,933 | — | — | — |
| Baker Douglas M JR | Director | Feb 5, 2025 | open-market buy | 16,000 | — | — | — |
| Smart Dalton | SVP Fin. - Global Controller | Jan 27, 2025 | award | 7,014 | — | — | — |
Questions
Are Merck insiders buying or selling?
Over the twelve months to November 1, 2026, 11 insiders at Merck sold $72M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $72M. Only open-market purchases and sales are counted.
Who sold the most Merck stock in the last year?
Zachary Jennifer (EVP, General Counsel) sold $25M in 4 open-market sales over the twelve months to November 1, 2026.
Do Merck executives sell under 10b5-1 plans?
0 of the 35 open-market sales in the last twelve months (0%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Merck
- Merck financial statements
- 1 tracked fund holding MRK
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.